Osprey Medical Inc. | Balance Sheet

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
18,099.50
14,146.90
16,197.60
30,180.20
41,085.30
Total Accounts Receivable
-
6.00
49.70
186.40
396.50
Inventories
145.30
284.10
413.10
360.40
974.50
Other Current Assets
467.20
148.80
134.00
85.40
184.70
Total Current Assets
18,712.00
14,585.80
16,794.40
30,812.20
42,640.90
Net Property, Plant & Equipment
259.00
309.30
347.60
755.20
873.60
Total Investments and Advances
4,660.10
15.00
16.80
-
-
Intangible Assets
163.00
162.90
166.00
149.60
122.50
Other Assets
30.50
-
-
16.90
15.70
Total Assets
23,824.50
15,072.90
17,324.80
31,733.90
43,652.70
Accounts Payable
612.90
299.20
416.20
573.90
712.70
Other Current Liabilities
717.70
1,140.00
857.50
1,249.90
1,562.80
Total Current Liabilities
1,330.50
1,439.20
1,273.70
1,823.80
2,275.50
Other Liabilities
68.80
60.00
49.60
29.20
5.50
Total Liabilities
1,399.30
1,499.20
1,323.30
1,853.00
2,281.10
Common Equity (Total)
22,425.20
13,573.70
16,001.50
29,880.90
41,371.60
Total Shareholders' Equity
22,425.20
13,573.70
16,001.50
29,880.90
41,371.60
Total Equity
22,425.20
13,573.70
16,001.50
29,880.90
41,371.60
Liabilities & Shareholders' Equity
23,824.50
15,072.90
17,324.80
31,733.90
43,652.70

About Osprey Medical

View Profile
Address
5600 Rowland Road
Minnetonka Minnesota 55343
United States
Employees -
Website http://www.ospreymed.com
Updated 09/14/2018
Osprey Medical, Inc. engages in the development, and commercialization of its proprietary products for the prevention of harmful effect of X-ray dye used during commonly performed angiographic imaging procedures. Its product includes Dyevert system, which is designed to reduce the amount of dye contrast injected into the patients during standard cardiovascular procedures. The company was founded by Frank Solomon, David Kaye, and James Edward Shapland on August 31, 2005 and is headquartered in Minnetonka, MN.